Analytical Data
-
基因名
RG9MTD3
- Application
-
别名
bA3J10.9 ; EC 2.1.1; FLJ31455; OTTHUMP00000021393; RG9D3; RNA (guanine 9 ) methyltransferase domain containing 3; RNA (guanine-9-)-methyltransferase domain-containing protein 3; RP11 3J10.9 ; TM10B_HUMAN; Trmt10b; tRNA methyltransferase 10 homolog B
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q6PF06
-
表达区间
1-316 aa
-
氨基酸序列
MDWKLEGSTQ KVESPVLQGQ EGILEETGED GLPEGFQLLQ IDAEGECQEG EILATGSTAW CSKNVQRKQR HWEKIVAAKK SKRKQEKERR KANRAENPGI CPQHSKRFLR ALTKDKLLEA KHSGPRLCID LSMTHYMSKK ELSRLAGQIR RLYGSNKKAD RPFWICLTGF TTDSPLYEEC VRMNDGFSSY LLDITEEDCF SLFPLETLVY LTPDSEHALE DVDLNKVYIL GGLVDESIQK KVTFQKAREY SVKTARLPIQ EYMVRNQNGK NYHSEILAIN QVFDILSTYL ETHNWPEALK KGVSSGKGYI LRNSVE
-
分子量
36.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RG9MTD3 is a recombinant protein that has garnered significant attention in the field of molecular biology and biotechnology due to its potential applications in therapeutic interventions and scientific research. This protein is part of a broader class of recombinant proteins that are engineered to mimic or enhance biological functions, making them valuable tools for studying protein interactions, signal transduction pathways, and cellular responses. The study of RG9MTD3 specifically emerged from the need to understand complex biological processes and to develop novel strategies for treating diseases. By harnessing recombinant DNA technology, researchers can produce RG9MTD3 in large quantities, facilitating detailed analyses of its structure and function. Investigations into RG9MTD3 have revealed its involvement in various physiological and pathological processes, prompting further exploration of its role in health and disease. As a result, RG9MTD3 represents not only a model for protein engineering studies but also a potential candidate for drug development, offering the promise of new treatments for conditions that currently pose significant challenges in medical science. The ongoing research into RG9MTD3 underscores the importance of recombinant proteins in advancing our understanding of biological systems and their potential in therapeutic applications.
